Patients with hidradenitis suppurativa experienced sustained ...

Results at Week 16 showed a significantly higher proportion of patients achieved a Hidradenitis Suppurativa Clinical Response (HiSCR) when ...

Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis ...

Patients With Hidradenitis Suppurativa Treated With Novartis ...

“HS is complex, painful, hard to treat and impacts patients' quality of life at very high levels,” Alexa Kimball, MD, MPH, an investigator at ...

Novartis Cosentyx® shows clinically meaningful symptom ...

HS is a chronic, inflammatory, debilitating skin condition with systemic comorbidities that has a profoundly negative effect on a patient's ...

Hidradenitis Suppurativa (HS) | HS Awareness | HCP

Patients with HS may deal with debilitating physical and emotional burdens. ... The chronic, systemic, and often progressive nature of the condition may lead to ...

Secukinumab in patients with moderate-to-severe hidradenitis ...

Secukinumab has previously been reported to have sustained efficacy with a favourable safety profile in patients with moderate-to-severe HS. It ...

HS Treatment Response Rates Continue to Improve with ...

The recent long-term data from the SUNSHINE 2 (NCT03713619) and SUNRISE 3 (NCT03713632) trials detailed more than 60% of patients were free of ...

Secukinumab in moderate-to-severe hidradenitis suppurativa ...

... hidradenitis suppurativa clinical response in the SUNRISE trial. Patient responses were sustained up to the end of the trials at week 52.

Secukinumab Shows Rapid, Sustained Improvement of Hidradenitis ...

... HS, with larger treatment effects observed as early as week 4. Fewer patients treated with secukinumab (Q2W/Q4W) experienced flares in the ...

Secukinumab in patients with moderate-to-severe hidradenitis ...

Secukinumab has previously been reported to have sustained efficacy with a favourable safety profile in patients with moderate-to-severe HS. It is unknown ...

Hidradenitis Suppurativa (Acne Inversa): Symptoms & Treatments

People with HS develop painful nodules, abscesses that drain pus and scarring over time. Women and people AFAB may experience flare-ups before their period.

Bimekizumab 48-week Phase 3 analyses in moderate to severe ...

People with HS experience flare-ups of the disease as well as severe pain, which can have a major impact on quality of life. ... HS develops in ...

Hidradenitis Suppurativa | Efficacy Data

Across 2 clinical trials, the percentages of patients on COSENTYX® experiencing ≥50% reduction in the number of inflammatory nodules and abscesses, ...

Hidradenitis Suppurativa: Diagnosis and Management in the ...

Patients typically report severe pain, purulent drainage, and concern about possible infection. Approximately one-half of patients with HS also experience ...

Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show ...

Hidradenitis suppurativa (HS) is a chronic, recurring, painful, and debilitating inflammatory skin disease. ... The main symptoms are nodules, ...

Secukinumab for Patients with Moderate-to-Severe Hidradenitis ...

Secukinumab Provides Sustained Improvements in Pain in Patients with Moderate-to-Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the ...

improving the lives of people with hidradenitis suppurativa (HS)

Ensure sustainable and equitable access to the most effective treatments for HS, both now and in the future. 5. Introduce a treatment guide for ...

Sustainable patient education in hidradenitis suppurativa

Hidradenitis suppurativa (HS) is a chronic inflammatory disease of recurrent painful nodules and sinus tracts mainly located in ...

Hidradenitis Suppurativa | COSENTYX® (secukinumab)

Hidradenitis suppurativa (HS) is a chronic, or long-lasting, inflammatory skin condition. It is thought that an overactive immune system may contribute to ...

Narrative Review and Update on Biologic and Small Molecule ...

Hidradenitis suppurativa (HS) is a chronic inflammatory entity characterized by the appearance of multiple nodules, abscesses, and fistulas, ...